Fiji Kava Limited (AU:CCO)
ASX:CCO
Top Page
Fiji Kava Limited
(Sydney:CCO)
Select Model
Select Model
Rating:44Neutral
Price Target:
AU$0.01
▲(0.00% Upside)
Action:ReiteratedDate:10/19/25
Fiji Kava Limited's overall stock score of 44 reflects significant challenges in financial performance, with persistent losses and liquidity issues weighing heavily. Valuation concerns due to a negative P/E ratio further dampen the outlook, while limited technical data and high volatility add uncertainty. Revenue and cash flow growth offer some hope, but are not enough to offset the risks.
Positive Factors
Revenue Growth
The company's revenue growth indicates increasing demand for its products, which can lead to improved market position and potential future profitability.
Negative Factors
High Leverage
High leverage poses a risk to financial stability, limiting the company's ability to invest in growth opportunities and manage economic downturns.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The company's revenue growth indicates increasing demand for its products, which can lead to improved market position and potential future profitability.
Read all positive factors
Fiji Kava Limited (CCO) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$10.56M
Dividend YieldN/A
Average Volume (3M)17.77M
Price to Earnings (P/E)―
Beta (1Y)1.36
Revenue Growth88.48%
EPS Growth51.61%
CountryAU
EmployeesN/A
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding3,520,496,000
10 Day Avg. Volume17,774,369
30 Day Avg. Volume17,774,369
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)2.60
Price to Sales (P/S)0.62
P/FCF Ratio-1.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Fiji Kava Limited Business Overview & Revenue Model
Company Description
The Calmer Co International Limited operates as a medicinal kava health and wellness company in Australia, New Zealand, Fiji, and the United States. It produces and sells noble kava extract capsules, and powder mixes under the Fiji Kava and Taki M...
How the Company Makes Money
Fiji Kava Limited generates revenue primarily through the sale of its kava products, which are marketed to health-conscious consumers looking for natural alternatives for relaxation and stress relief. The company has established key revenue stream...
Fiji Kava Limited Financial Statement Overview
Summary
Income Statement
25
Negative
Balance Sheet
30
Negative
Cash Flow
35
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.10M | 8.03M | 4.26M | 1.78M | 2.05M | 1.16M |
| Gross Profit | 2.27M | 3.48M | 2.05M | -1.40M | 236.14K | 404.43K |
| EBITDA | -2.26M | -3.45M | -3.34M | -4.86M | -5.72M | -3.19M |
| Net Income | -3.37M | -3.99M | -3.73M | -5.24M | -5.92M | -3.39M |
Balance Sheet | ||||||
| Total Assets | 5.49M | 5.68M | 4.33M | 3.24M | 4.79M | 3.60M |
| Cash, Cash Equivalents and Short-Term Investments | 1.06M | 1.46M | 1.10M | 462.15K | 814.06K | 1.18M |
| Total Debt | 4.30M | 2.31M | 2.21M | 2.35M | 1.78M | 267.12K |
| Total Liabilities | 5.31M | 3.78M | 4.80M | 3.32M | 2.51M | 694.78K |
| Stockholders Equity | 187.33K | 1.90M | -466.84K | -87.53K | 2.28M | 2.91M |
Cash Flow | ||||||
| Free Cash Flow | -2.96M | -4.83M | -2.19M | -3.82M | -7.10M | -4.40M |
| Operating Cash Flow | -2.92M | -4.37M | -2.08M | -3.80M | -6.14M | -4.14M |
| Investing Cash Flow | -22.64K | -459.91K | -116.97K | -21.08K | -964.94K | -259.37K |
| Financing Cash Flow | 1.84M | 5.19M | 2.83M | 3.47M | 6.74M | 4.16M |
Fiji Kava Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
44 Neutral | AU$10.56M | -1.73 | -322.76% | ― | 88.48% | 51.61% | |
44 Neutral | AU$8.04M | -3.85 | -35.12% | ― | 63.30% | 70.00% | |
42 Neutral | AU$6.66M | -0.01 | 226.76% | ― | -21.84% | 79.99% | |
41 Neutral | AU$8.74M | -1.62 | -44.35% | ― | -18.70% | 20.83% |
* Consumer Defensive Sector Average
AU:CCO
Fiji Kava Limited
―
―
―
AU:EVE
EVE Health Group Limited
0.03
>-0.01
-16.67%
AU:NGS
Nutritional Growth Solutions Ltd.
0.02
>-0.01
-33.33%
AU:OMG
Forbidden Foods Ltd
0.01
-0.01
-50.00%
Fiji Kava Limited Corporate Events
FDA Ruling on Kava as Food Bolsters The Calmer Co.’s U.S. and Amazon Growth Strategy
Dec 23, 2025
The U.S. Food and Drug Administration has confirmed that traditionally prepared kava beverages made solely from kava root and water are recognised as food under federal law, providing crucial regulatory clarity for The Calmer Co.’s kava powd...
The Calmer Co Options Expire, Simplifying Capital Structure
Dec 23, 2025
The Calmer Co International Limited has announced the cessation of 172,241,016 listed options (ASX code CCOAM), which expired on 11 December 2025 without being exercised. The expiry of these options reduces the company’s pool of potential di...
The Calmer Co. Completes $1.4 Million Convertible Note Raise to Drive Growth
Dec 17, 2025
The Calmer Co. International Limited has successfully closed the second tranche of its $1.4 million secured Convertible Note raise, with $700,000 secured in Tranche 2. The funds will be used to support inventory growth for its wholesale division a...
The Calmer Co. Secures Shareholder Approval for AGM Resolutions
Nov 28, 2025
The Calmer Co. International Limited announced that all resolutions proposed at its Annual General Meeting were passed by the required majority, marking a successful outcome for the company. This development is likely to positively impact the comp...
Leadership Change at The Calmer Co International Limited
Nov 6, 2025
The Calmer Co International Limited has announced the resignation of John Homewood from its board of directors, effective November 7, 2025. This change in leadership could potentially impact the company’s strategic direction and stakeholder ...
The Calmer Co Issues 700,000 Unquoted Convertible Notes
Oct 30, 2025
The Calmer Co International Limited has announced the issuance of 700,000 unquoted convertible notes, as part of a previously announced transaction. This move is part of the company’s strategic financial maneuvers, potentially impacting its ...
The Calmer Co International Limited Announces 2025 AGM Details
Oct 29, 2025
The Calmer Co International Limited has announced its upcoming Annual General Meeting (AGM), scheduled to take place on November 28, 2025, at the offices of HWL Ebsworth Lawyers in Brisbane, Queensland. The agenda includes the presentation of the ...
Fiji Kava Limited Reports Exceptional Q1 2026 Sales Growth
Oct 28, 2025
Fiji Kava Limited has reported exceptional sales momentum in the first quarter of 2026, with significant growth across all channels. The company has streamlined its business model, resulting in strong global sales growth and reduced costs, which i...
The Calmer Co. Reports Record Quarterly Revenue and Strategic Growth
Oct 28, 2025
The Calmer Co. International Limited, operating in the wellness industry, focuses on diversified sales channels including retail, e-commerce, and wholesale, with a strong presence in Australia and the United States. The company, known for its kava...
Director’s Interest Notice: Zane Yoshida Increases Holdings in The Calmer Co
Oct 17, 2025
The Calmer Co International Limited has announced a change in the director’s interest notice, specifically involving Zane Yoshida. The announcement details the acquisition of 20 million fully paid ordinary shares (FPOS) by UMI7 Investments P...
The Calmer Co. Issues 47 Million Shares to Bolster Market Position
Oct 17, 2025
The Calmer Co. International Limited has issued 47 million fully paid ordinary shares as part of its share plan, without requiring disclosure to investors under specific provisions of the Corporations Act 2001. This strategic move, authorized by t...
The Calmer Co International Limited Announces Quotation of New Securities
Oct 17, 2025
The Calmer Co International Limited, identified by the ASX issuer code CCO, has announced the quotation of 47,000,000 ordinary fully paid securities on the Australian Securities Exchange (ASX). These securities, issued under an employee incentive ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.